SCHEMBL25548153

SCHEMBL25548153

c1ccc(-n2nc3ccc4ccc5ccc(-c6cc(-c7cccc(-c8ccc9ccccc9c8)c7)nc(-c7cccc(-c8ccc9ccccc9c8)c7)n6)cc5c4c3n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.39
CYP1B1 Q16678 1/20 0.39
ALOX5 P09917 1/20 0.38
CYP1A2 P05177 1/20 0.35
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
KDM4E B2RXH2 4/20 0.34
ALDH1A1 P00352 3/20 0.34
MAPT P10636 3/20 0.34
HPGD P15428 3/20 0.34
LMNA P02545 2/20 0.34
PARP1 P09874 1/20 0.33
GLA P06280 1/20 0.33
CTRC Q99895 1/20 0.32
NPC1 O15118 1/20 0.32
STAT1 P42224 1/20 0.32
RAB9A P51151 1/20 0.32
MAOA P21397 1/20 0.32
MAOB P27338 1/20 0.32
PIM1 P11309 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25548149 0.99 CYP1A1 (0.41) CYP1A1CYP1B1ALOX5CYP1A2MEN1
SCHEMBL25548151 0.96 CYP1A1 (0.43) CYP1A1CYP1B1ALOX5CYP1A2MEN1
SCHEMBL25548152 0.96 ALOX5 (0.41) CYP1A1CYP1B1ALOX5CYP1A2MEN1
SCHEMBL25548145 0.95 ALOX5 (0.40) ALOX5CYP1A2MEN1KMT2AKDM4E
SCHEMBL25548147 0.95 ALOX5 (0.38) ALOX5MEN1KMT2AKDM4EALDH1A1
SCHEMBL25548279 0.94 ALOX5 (0.40) ALOX5CYP1A2MEN1KMT2AKDM4E
SCHEMBL25548142 0.94 ALOX5 (0.40) ALOX5CYP1A2MEN1KMT2AKDM4E
SCHEMBL25548148 0.94 MEN1 (0.39) ALOX5MEN1KMT2AKDM4EALDH1A1
SCHEMBL25548143 0.90 ALOX5 (0.42) CYP1A1CYP1B1ALOX5CYP1A2MEN1
SCHEMBL25548144 0.90 ALOX5 (0.43) CYP1A1CYP1B1ALOX5CYP1A2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167089-A1 ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF NINGBO LUMILAN ADVANCED MATERIALS CO., LTD. (CN) 2023-06-01 US disclosed
US-20230167089-A1 ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF NINGBO LUMILAN ADVANCED MATERIALS CO., LTD. (CN) 2023-06-01 US disclosed
US-20230157161-A1 ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF NINGBO LUMILAN ADVANCED MATERIALS CO., LTD. (CN) 2023-05-18 US disclosed
US-20230157161-A1 ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF NINGBO LUMILAN ADVANCED MATERIALS CO., LTD. (CN) 2023-05-18 US disclosed
US-20230134923-A1 ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF NINGBO LUMILAN ADVANCED MATERIALS CO., LTD. (CN) 2023-05-04 US disclosed
US-20230134923-A1 ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF NINGBO LUMILAN ADVANCED MATERIALS CO., LTD. (CN) 2023-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167089-A1 ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF PIEZO1, VCL, VDAC3 CYP1A1 1376/4885CYP1B1 1916/4885ALOX5 977/4885
US-20230134923-A1 ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF PIEZO1, VCL, VDAC3 CYP1A1 1376/4885CYP1B1 1916/4885ALOX5 977/4885
US-20230157161-A1 ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF PIEZO1, VCL, VDAC3 CYP1A1 1376/4885CYP1B1 1916/4885ALOX5 977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.